Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.61 is 56% below its 5-year average of 12.87, near the low end of its 5-year range (5.61–34.40).
As of the fiscal period ended Tuesday, June 30, 2026. 28.33% below its 12-month average of 7.83.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.61.
QUICK RATIO (ACID-TEST)
5.61
QUICK RATIO (ACID-TEST) AVG TTM
7.83
QUICK RATIO (ACID-TEST) AVG 3Y
9.24
QUICK RATIO (ACID-TEST) AVG 5Y
12.87
QUICK RATIO (ACID-TEST) AVG 10Y
14.16
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-28.33%
CURRENT VS 3Y AVG
-39.23%
CURRENT VS 5Y AVG
-56.38%
CURRENT VS 10Y AVG
-60.36%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.92
median of 460 covered companies
CURRENT VS SECTOR MEDIAN
+92.22%
vs the sector median at left
AnaptysBio, Inc.
Market Cap
$1.46B
Quick Ratio (Acid-Test)
5.61
TTM Avg
7.83
3Y Avg
9.24
5Y Avg
12.87
Market Cap
$1.45B
Quick Ratio (Acid-Test)
2.94
TTM Avg
3.04
3Y Avg
2.84
5Y Avg
2.90
Market Cap
$1.43B
Quick Ratio (Acid-Test)
35.85
TTM Avg
18.03
3Y Avg
18.03
5Y Avg
18.03
Market Cap
$1.51B
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.52B
Quick Ratio (Acid-Test)
28.70
TTM Avg
25.68
3Y Avg
28.23
5Y Avg
39.61
Market Cap
$1.52B
Quick Ratio (Acid-Test)
15.18
TTM Avg
8.03
3Y Avg
6.72
5Y Avg
22.81
Market Cap
$1.52B
Quick Ratio (Acid-Test)
1.30
TTM Avg
1.23
3Y Avg
1.77
5Y Avg
3.05
Market Cap
$1.39B
Quick Ratio (Acid-Test)
5.07
TTM Avg
3.94
3Y Avg
5.82
5Y Avg
6.31
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AnaptysBio, Inc. (ANAB) | $1.46B | 5.61 | 7.83 | 9.24 | 12.87 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 2.94 | 3.04 | 2.84 | 2.90 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | 35.85 | 18.03 | 18.03 | 18.03 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | 28.70 | 25.68 | 28.23 | 39.61 |
| Innoviva, Inc. (INVA)vs › | $1.52B | 15.18 | 8.03 | 6.72 | 22.81 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 1.30 | 1.23 | 1.77 | 3.05 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | 5.07 | 3.94 | 5.82 | 6.31 |
| Certara, Inc. (CERT)vs › | $1.57B | 2.55 | 2.09 | 2.53 | 2.95 |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.34B | 11.09 | 7.43 | 12.87 | 13.91 |
Quick Ratio
5.61
Excludes inventory
Current Ratio
5.61
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.61 |
| 2026-03-31 | 7.58 |
| 2025-12-31 | 9.07 |
| 2025-09-30 | 8.68 |
| 2025-06-30 | 8.22 |
| 2025-03-31 | 8.25 |
| 2024-12-31 | 9.51 |
| 2024-09-30 | 10.23 |
| 2024-06-30 | 9.09 |
| 2024-03-31 | 11.53 |
| 2023-12-31 | 10.87 |
| 2023-09-30 | 10.92 |
| 2023-06-30 | 10.53 |
| 2023-03-31 | 12.21 |
| 2022-12-31 | 17.16 |
| 2022-09-30 | 21.39 |
| 2022-06-30 | 22.79 |
| 2022-03-31 | 25.90 |
| 2021-12-31 | 34.40 |
| 2021-09-30 | 18.51 |
| 2021-06-30 | 19.31 |
| 2021-03-31 | 26.74 |
| 2020-12-31 | 20.01 |
| 2020-09-30 | 14.13 |
| 2020-06-30 | 19.10 |
| 2020-03-31 | 15.96 |
| 2019-12-31 | 12.79 |
| 2019-09-30 | 14.28 |
| 2019-06-30 | 14.07 |
| 2019-03-31 | 17.05 |
| 2018-12-31 | 19.89 |
| 2018-09-30 | 24.10 |
| 2018-06-30 | 16.19 |
| 2018-03-31 | 17.57 |
| 2017-12-31 | 17.93 |
| 2017-09-30 | 10.77 |
| 2017-06-30 | 11.49 |
| 2017-03-31 | 13.56 |
| 2016-12-31 | 10.20 |
| 2016-09-30 | 6.94 |
| 2016-06-30 | 6.24 |
| 2016-03-31 | 7.22 |
| 2015-12-31 | 7.25 |
| 2015-09-30 | 6.04 |
| 2015-06-30 | 2.01 |
| 2015-03-31 | 1.96 |
| 2014-12-31 | 2.09 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
